Press Release4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 ...
Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...
Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under ...
HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to ...
Its time for Indian pharma companies to look beyond the U.S. market as the Trump administration has threatened to impose 25% tariff on pharmaceutical imports. This move would disrupt India’s ...
Aveo Pharmaceuticals, a Mumbai-based drugmaker ... Aveo said other companies have copied its brand name and logo and it has sued such companies and the matter is pending in the court. A recent BBC ...
Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. The boss of German healthcare company Stada says his business is a better bet than Big Pharma ...
SAN RAFAEL, Calif., Feb. 24, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has appointed Timothy P. Walbert, former chairman, president and ...
Image credit: Shutterstock / Tada Images. Figures from across the pharmaceutical and medtech industry have spoken out on social media following the culling of staff at US healthcare agencies, with ...
Is it the smoothness of running shoes or the convenience of your favourite gym shorts? Or maybe those famous logos let you know at a glance which brand you’re dealing with. In athletic apparel, logos ...
Trump told reporters on Tuesday that sectoral tariffs on pharmaceuticals and semiconductor chips would also start at "25 per cent or higher, and it will go very substantially higher over the ...
Feb 19 (Reuters) - An index of Indian pharmaceutical company shares (.NIPHARM), opens new tab slid 2% to its lowest level in seven months on Wednesday after U.S. President Donald Trump said he ...